Development

Indian Innovation Systems and Emergence of Biopharmaceutical Sector: Issues and Prospects

January 1, 2007

RIS

Abstract

The prospective entry of generic dominated Indian pharmaceutical sector in the ambit of new technologies is likely to give filip to emergence of strong biopharmaceutical sector.It is pertinent in this context to draw a policy roadmap which takes into account sectoral dynamics and draws upon regional and international linkages. An appropriate balance between national system of innovation (NSI) and sectoral system of innovation (SSI) would determine trajactory of growth of this sector.

CONNECT WITH THE WORLD'S
TOP ASIA ANALYSTS

Sign up to receive free daily think pieces from leading analysts or our weekly digest, that includes our editorial and a collection of recent articles in brief.

EABER Member Institutions

© 2026 East Asian Bureau of Economic Research. All rights reserved.